Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2012-08-31

Clinical Trial Update: Chondroitin Sulfate for Crohn's Disease [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating chondroitin sulfate for Crohn's disease was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chondroitin sulfate (chondroitin sulfate)

Snippet

Sponsor: University Hospitals Cleveland Medical Center | Conditions: Crohn's Disease | Phase 1, Phase 2 | Status: WITHDRAWN